Jinling Pharmaceutical Co Ltd (000919) — Cash Flow Reinvestment Rate
Jinling Pharmaceutical Co Ltd (000919) has a Cash Flow Reinvestment Rate of 0.17x as of September 2025, reinvesting CN¥12.56 Million (capex CN¥12.56 Million ) from operating cash flow of CN¥74.01 Million. See 000919 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jinling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for Jinling Pharmaceutical Co Ltd across 26 annual periods. For the full cash flow conversion analysis, see how efficiently does Jinling Pharmaceutical Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Jinling Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for Jinling Pharmaceutical Co Ltd. See 000919 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.80x | CN¥739.80 Million | CN¥154.19 Million | CN¥201.63 Million | ▲ +80.7% |
| 2023 | 2.65x | CN¥421.94 Million | CN¥158.92 Million | CN¥186.25 Million | ▲ +30.4% |
| 2022 | 2.04x | CN¥530.76 Million | CN¥260.59 Million | CN¥309.64 Million | ▲ +264.2% |
| 2021 | 0.56x | CN¥163.32 Million | CN¥292.03 Million | CN¥162.76 Million | ▼ -57.7% |
| 2020 | 1.32x | CN¥412.12 Million | CN¥311.46 Million | CN¥291.41 Million | ▲ +104.1% |
| 2019 | 0.65x | CN¥302.01 Million | CN¥465.85 Million | CN¥125.71 Million | ▲ +4.0% |
| 2018 | 0.62x | CN¥270.52 Million | CN¥433.83 Million | CN¥136.42 Million | ▲ +259.1% |
| 2017 | 0.17x | CN¥76.94 Million | CN¥443.11 Million | CN¥66.80 Million | ▼ -87.0% |
| 2016 | 1.34x | CN¥128.57 Million | CN¥96.15 Million | CN¥107.45 Million | ▲ +56.2% |
| 2015 | 0.86x | CN¥181.83 Million | CN¥212.45 Million | CN¥104.31 Million | ▲ +181.6% |
| 2014 | 0.30x | CN¥91.14 Million | CN¥299.89 Million | CN¥91.14 Million | ▼ -42.8% |
| 2013 | 0.53x | CN¥144.05 Million | CN¥271.21 Million | CN¥144.05 Million | ▼ -34.7% |
| 2012 | 0.81x | CN¥188.76 Million | CN¥232.12 Million | CN¥188.76 Million | ▲ +71.0% |
| 2011 | 0.48x | CN¥82.20 Million | CN¥172.82 Million | CN¥82.20 Million | ▼ -11.4% |
| 2010 | 0.54x | CN¥95.48 Million | CN¥177.81 Million | CN¥95.48 Million | ▲ +4.7% |
| 2009 | 0.51x | CN¥96.60 Million | CN¥188.41 Million | CN¥96.60 Million | ▲ +607.8% |
| 2008 | 0.07x | CN¥22.11 Million | CN¥305.26 Million | CN¥22.11 Million | ▼ -59.2% |
| 2007 | 0.18x | CN¥20.97 Million | CN¥118.06 Million | CN¥20.97 Million | ▲ +6.5% |
| 2006 | 0.17x | CN¥23.09 Million | CN¥138.50 Million | CN¥23.09 Million | ▼ -50.2% |
| 2005 | 0.33x | CN¥36.61 Million | CN¥109.29 Million | CN¥36.61 Million | ▼ -26.1% |
| 2004 | 0.45x | CN¥72.47 Million | CN¥159.81 Million | CN¥72.47 Million | ▲ +29.4% |
| 2003 | 0.35x | CN¥56.73 Million | CN¥161.86 Million | CN¥56.73 Million | ▼ -55.5% |
| 2002 | 0.79x | CN¥102.63 Million | CN¥130.36 Million | CN¥102.63 Million | ▼ -54.6% |
| 2001 | 1.73x | CN¥160.27 Million | CN¥92.49 Million | CN¥160.27 Million | ▲ +198.0% |
| 2000 | 0.58x | CN¥134.49 Million | CN¥231.31 Million | CN¥134.49 Million | ▼ -67.7% |
| 1999 | 1.80x | CN¥71.57 Million | CN¥39.77 Million | CN¥71.57 Million | — |